Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of cystatin SN and AFP in preparing markers for diagnosis and prediction of liver cancer

A marker and inhibitor technology, applied in the field of medical detection, can solve the problem that the specificity and sensitivity of liver cancer cannot meet the monitoring of liver cancer, etc., and achieve the effects of portability, convenience and good repeatability.

Active Publication Date: 2016-03-16
SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Alpha-fetoprotein (AFP) is the most commonly used tumor molecular marker for monitoring liver cancer worldwide, but the proportion of AFP-negative liver cancer in new cases is increasing, and the specificity and sensitivity of AFP in diagnosing liver cancer can no longer meet the role of monitoring liver cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of cystatin SN and AFP in preparing markers for diagnosis and prediction of liver cancer
  • Application of cystatin SN and AFP in preparing markers for diagnosis and prediction of liver cancer
  • Application of cystatin SN and AFP in preparing markers for diagnosis and prediction of liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 Establishment of CystatinSN Serum Detection Reaction System and Its Optimization

[0025] Coat the ELISA plate with a mouse anti-human CystatinSN monoclonal antibody at a concentration of 5 μg / mL, coat it overnight at 4°C, and wash the plate; then block it in 2% BSA at room temperature for 2 hours, and wash the plate; then The CystatinSN protein standard (encoded CystatinSN protein amino acid sequence such as SEQ ID NO.1) and serum samples Add them to the blocking plate respectively, react at 37°C for 1 hour, and wash the plate; then use the rabbit anti-human CystatinSN polyclonal antibody labeled with HRP at a concentration of 0.5 μg / mL, react at 37°C for 1 hour, and wash the plate; Base benzidine (TMB) for 2-3 minutes, and finally stop the reaction with 2M sulfuric acid, and detect the OD value under the condition of 450nm ( figure 1 ). Depend on figure 1 It can be seen that the linear range of the CystatinSN enzyme-linked immunoassay kit is 50pg / mL-1600p...

Embodiment 2

[0032] Embodiment 2 CystatinSN enzyme-linked immunoassay kit

[0033]According to the establishment of the CystatinSN serum detection system in Example 1, the CystatinSN enzyme-linked immunoassay kit was constructed, and the specific components are as shown in Table 1:

[0034] Table 1. CystatinSN ELISA Kit Components

[0035]

[0036]

[0037] Evaluation of CystatinSN ELISA kit: Use CystatinSN ELISA kit to detect CystatinSN positive quality control products, and repeat the detection 10 times at two levels of CystatinSN protein concentration of 160pg / mL and 80pg / mL respectively, the results show the coefficient of variation CV ≤10%; if 3 batches of kits are used to detect the same sample, the inter-assay coefficient of variation (CV) of the 3 batches of kits is ≤15%. The research on the stability of the kit shows that it can be stored at 4°C for 8 months, stored at 4°C for 2 months after opening, and transported at 0-4°C for 7 days.

Embodiment 3A

[0038] Example 3 AFP enzyme-linked immunosorbent assay (ELISA) detection kit

[0039] The AFP-ELISA detection kit uses the product of Beijing Rejing Biotechnology Co., Ltd. (Cat. No. 1003). The amino acid sequence of the detected AFP marker is shown in SEQ ID NO.2.

[0040] The CystatinSN ELISA detection kit constructed in Example 2 was combined with the AFP-ELISA detection kit in this example to form a CystatinSN-AFP combined detection kit.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
recovery rateaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a combined application of a cystatin SN and an alpha-fetoprotein (AFP), and particularly discloses the application of the cystatin SN and the AFP in preparation of a marker for diagnosis and predicting of liver cancer. The invention also discloses a capture agent of the liver cancer marker. A liver cancer detection kit is formed by combining the capture agent with conventional reagents. The obtained kit has the advantages of good specificity, high sensitivity and the like, can be used for early diagnosis of liver cancer, therapeutic effect evaluation in a therapeutic process and monitoring of metastasis and recurrence after therapy, and has test results sooner than clinical symptoms.

Description

technical field [0001] The invention belongs to the field of medical detection, and relates to the application of CystatinSN and AFP in preparing markers for diagnosis and prediction of liver cancer. Background technique [0002] Liver cancer is the fifth most common tumor in the world. According to the report of the World Health Organization, the growth rate of liver cancer mortality is the second fastest among all cancers. More than 500,000 people worldwide suffer from liver cancer every year, and more than half of them are in China. HCC incidence and mortality rates are almost identical, predicting poor overall survival for HCC. Therefore, finding appropriate tumor molecular markers to achieve early diagnosis of liver cancer, efficacy evaluation, and recurrence monitoring is of great value in reducing liver cancer mortality and improving the survival status of liver cancer patients. [0003] Liver cirrhosis is an important risk factor for the development of liver cancer...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574G01N33/577G01N33/68
CPCG01N33/57438G01N33/57484G01N2333/471G01N2333/8139G01N2800/52G01N2800/54
Inventor 王弢秦勇吴孝林
Owner SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD